Cargando…
Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer
The current immunotherapy strategy for breast cancer is limited. Tumor neoantigens have been proven to be a promising biomarker and potential target of immunotherapy in a variety of tumors. However, their effectiveness for breast cancer remains unclear. Immunogenic cell death (ICD) is a regulated fo...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641162/ https://www.ncbi.nlm.nih.gov/pubmed/36393842 http://dx.doi.org/10.3389/fcell.2022.962389 |